125 related articles for article (PubMed ID: 1380608)
1. Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure.
Fitzpatrick MA; Rademaker MT; Charles CJ; Yandle TG; Espiner EA; Ikram H; Sybertz E
J Cardiovasc Pharmacol; 1992 Apr; 19(4):635-40. PubMed ID: 1380608
[TBL] [Abstract][Full Text] [Related]
2. Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure.
Rademaker MT; Fitzpatrick MA; Charles CJ; Richards AM; Nicholls MG; Espiner EA; Sybertz E
J Cardiovasc Pharmacol; 1996 Mar; 27(3):439-46. PubMed ID: 8907807
[TBL] [Abstract][Full Text] [Related]
3. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure.
Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T
Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410
[TBL] [Abstract][Full Text] [Related]
4. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
[TBL] [Abstract][Full Text] [Related]
5. Effects of the selective neutral endopeptidase inhibitor, retrothiorphan, on renal function and blood pressure in conscious normotensive Wistar and hypertensive DOCA-salt rats.
Pham I; el Amrani AI; Fournié-Zaluski MC; Corvol P; Roques B; Michel JB
J Cardiovasc Pharmacol; 1992 Dec; 20(6):847-57. PubMed ID: 1282584
[TBL] [Abstract][Full Text] [Related]
6. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt.
Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R
Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733
[TBL] [Abstract][Full Text] [Related]
7. Concurrent neutral endopeptidase and ACE inhibition in experimental heart failure: renal and hormonal effects.
Helin K
Scand J Clin Lab Invest; 1993 Dec; 53(8):843-51. PubMed ID: 8140395
[TBL] [Abstract][Full Text] [Related]
8. Clearance receptors and endopeptidase 24.11: equal role in natriuretic peptide metabolism in conscious sheep.
Charles CJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG; Protter A; Kosoglou T
Am J Physiol; 1996 Aug; 271(2 Pt 2):R373-80. PubMed ID: 8770137
[TBL] [Abstract][Full Text] [Related]
9. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.
Rademaker MT; Scott NJA; Koh CY; Kini RM; Richards AM
Cardiovasc Res; 2021 Jan; 117(2):508-519. PubMed ID: 32167565
[TBL] [Abstract][Full Text] [Related]
10. Hormonal, renal, hemodynamic responses to acute neutral endopeptidase inhibition in heart transplant patients.
Piquard F; Richard R; Charloux A; Doutreleau S; Hannedouche T; Brandenberger G; Geny B
J Appl Physiol (1985); 2002 Aug; 93(2):569-75. PubMed ID: 12133866
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic and hormonal effects of neutral endopeptidase inhibitor SCH 39370 in sheep.
Charles CJ; Espiner EA; Cameron VA; Richards AM; Yandle TG; Sybertz EJ
Hypertension; 1991 May; 17(5):643-51. PubMed ID: 1850715
[TBL] [Abstract][Full Text] [Related]
12. Effect of neutral endopeptidase inhibitor in rats with congestive heart failure.
Murohara Y; Johnston CI
Clin Exp Pharmacol Physiol; 1992 May; 19(5):380-3. PubMed ID: 1325886
[TBL] [Abstract][Full Text] [Related]
13. Cardiorenal actions of neutral endopeptidase inhibition in experimental congestive heart failure.
Cavero PG; Margulies KB; Winaver J; Seymour AA; Delaney NG; Burnett JC
Circulation; 1990 Jul; 82(1):196-201. PubMed ID: 2142023
[TBL] [Abstract][Full Text] [Related]
14. Hemodynamic and humoral effects of chronic treatment with the neutral endopeptidase inhibitor SCH 42495 in spontaneously hypertensive rats.
Sala C; Monopoli A; Casati C; Ardeleani G; Ongini E; Zanchetti A; Morganti A
J Cardiovasc Pharmacol; 1994 May; 23(5):703-8. PubMed ID: 7521451
[TBL] [Abstract][Full Text] [Related]
15. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive and renal activity of SQ 28,603, an inhibitor of neutral endopeptidase.
Seymour AA; Norman JA; Asaad MM; Fennell SA; Little DK; Kratunis VJ; Rogers WL
J Cardiovasc Pharmacol; 1991 Feb; 17(2):296-304. PubMed ID: 1709235
[TBL] [Abstract][Full Text] [Related]
17. Prolonged neutral endopeptidase inhibition in heart failure.
Helin K; Tikkanen I; Tikkanen T; Saijonmaa O; Sybertz EJ; Vemulapalli S; Sariola H; Fyhrquist F
Eur J Pharmacol; 1991 May; 198(1):23-30. PubMed ID: 1655477
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic neutral endopeptidase inhibition and the natriuretic response to acute volume expansion.
Scheuermann M; Dietz R; Willenbrock R
Eur J Pharmacol; 1998 Apr; 347(2-3):245-52. PubMed ID: 9653889
[TBL] [Abstract][Full Text] [Related]
19. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neutral endopeptidase 3.4.24.11 in conscious dogs with pacing induced heart failure.
Seymour AA; Asaad MM; Lanoce VM; Fennell SA; Cheung HS; Rogers WL
Cardiovasc Res; 1993 Jun; 27(6):1015-23. PubMed ID: 8221758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
